Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1677 USD | -4.17% | -4.34% | -32.84% |
Apr. 12 | North American Morning Briefing : Big Banks Kick -2- | DJ |
Apr. 01 | Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024 |
Financials (USD)
Sales 2024 * | 9.99M | Sales 2025 * | 11.99M | Capitalization | 4.1M |
---|---|---|---|---|---|
Net income 2024 * | -6M | Net income 2025 * | -5M | EV / Sales 2024 * | 0.41 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.34 x |
P/E ratio 2024 * |
-0.39
x | P/E ratio 2025 * |
-0.49
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.83% |
Latest transcript on ReShape Lifesciences Inc.
1 day | -4.17% | ||
1 week | -4.34% | ||
Current month | +1.02% | ||
1 month | -3.45% | ||
3 months | -10.66% | ||
6 months | -27.28% | ||
Current year | -32.84% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Hickey
CEO | Chief Executive Officer | 59 | 20-01-31 |
Director of Finance/CFO | 63 | 21-06-14 | |
Dov Gal
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Blackford
BRD | Director/Board Member | 66 | 15-12-31 |
Dan Gladney
CHM | Chairman | 70 | 15-10-31 |
Director/Board Member | 70 | 21-06-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 0.175 | +0.52% | 241,469 |
24-05-07 | 0.1741 | +4.06% | 189,119 |
24-05-06 | 0.1673 | -1.18% | 102,902 |
24-05-03 | 0.1693 | -3.42% | 72,857 |
24-05-02 | 0.1753 | +4.97% | 232,231 |
Delayed Quote Nasdaq, May 09, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.84% | 4.1M | |
+8.88% | 219B | |
+8.68% | 185B | |
+14.25% | 135B | |
+28.18% | 107B | |
+14.65% | 51.28B | |
+4.48% | 51.01B | |
+4.39% | 41.85B | |
+7.00% | 37.02B | |
+26.06% | 31.27B |
- Stock Market
- Equities
- RSLS Stock